Total Payments
$17,125
2024 Payments
$10,491
Companies
30
Transactions
250
Medicare Patients
2,809
Medicare Billing
$665,942
Payment Breakdown by Category
Other$8,258 (48.2%)
Food & Beverage$4,856 (28.4%)
Travel$2,174 (12.7%)
Consulting$1,539 (9.0%)
Education$298.43 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,258 | 4 | 48.2% |
| Food and Beverage | $4,856 | 236 | 28.4% |
| Travel and Lodging | $2,174 | 2 | 12.7% |
| Consulting Fee | $1,539 | 1 | 9.0% |
| Education | $298.43 | 7 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $12,780 | 35 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $699.82 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $682.48 | 33 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $531.07 | 26 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $242.27 | 14 | $0 (2022) |
| Relypsa, Inc. | $205.33 | 13 | $0 (2019) |
| CALLIDITAS THERAPEUTICS US INC. | $196.57 | 9 | $0 (2024) |
| Amgen Inc. | $177.66 | 9 | $0 (2024) |
| ANI Pharmaceuticals, Inc. | $164.59 | 8 | $0 (2024) |
| Vifor Pharma, Inc. | $143.97 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,491 | 51 | Bayer Healthcare Pharmaceuticals Inc. ($9,602) |
| 2023 | $2,051 | 45 | Bayer Healthcare Pharmaceuticals Inc. ($1,172) |
| 2022 | $2,461 | 43 | Bayer HealthCare Pharmaceuticals Inc. ($1,818) |
| 2021 | $675.06 | 30 | Mallinckrodt Hospital Products Inc. ($196.98) |
| 2020 | $142.38 | 10 | Otsuka America Pharmaceutical, Inc. ($48.41) |
| 2019 | $414.30 | 15 | Otsuka America Pharmaceutical, Inc. ($113.33) |
| 2018 | $435.85 | 25 | Relypsa, Inc. ($84.28) |
| 2017 | $454.75 | 31 | OPKO Pharmaceuticals, LLC ($90.45) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: NEPHROLOGY | ||||||
| 11/26/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/21/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 10/30/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.47 | General |
| 10/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.70 | General |
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Nephrology | ||||||
| 08/28/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $15.90 | General |
| 08/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,075.00 | General |
| Category: Cardio-renal | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $1,262.25 | General |
| Category: Cardio-renal | ||||||
| 07/25/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $42.99 | General |
| Category: NEPHROLOGY | ||||||
| 07/24/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Inflammation | ||||||
| 07/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 587 | 1,226 | $380,637 | $129,045 |
| 2022 | 12 | 684 | 1,516 | $469,813 | $156,288 |
| 2021 | 14 | 686 | 1,678 | $545,740 | $184,513 |
| 2020 | 14 | 852 | 2,061 | $670,175 | $196,095 |
Total Patients
2,809
Total Services
6,481
Medicare Billing
$665,942
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 19 | 129 | $109,779 | $34,466 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 302 | $51,730 | $28,256 | 54.6% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 12 | 81 | $68,931 | $17,712 | 25.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 114 | 295 | $56,050 | $17,662 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 196 | $23,772 | $11,990 | 50.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 48 | $13,335 | $4,754 | 35.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 35 | 66 | $21,450 | $3,608 | 16.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $9,180 | $3,576 | 39.0% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 18 | 54 | $18,090 | $3,511 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $8,320 | $3,510 | 42.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 21 | 175 | $148,925 | $47,693 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 286 | $45,045 | $25,961 | 57.6% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 12 | 101 | $85,951 | $21,812 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 127 | 376 | $63,439 | $20,377 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 213 | $23,326 | $12,944 | 55.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 49 | 131 | $42,575 | $7,336 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $13,490 | $5,664 | 42.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 39 | 49 | $14,985 | $5,017 | 33.5% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 21 | 56 | $18,760 | $3,706 | 19.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $7,875 | $3,627 | 46.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 23 | 29 | $2,987 | $1,359 | 45.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 22 | 27 | $2,455 | $792.94 | 32.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 32 | 267 | $227,217 | $73,692 | 32.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 147 | 501 | $72,645 | $27,587 | 38.0% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 12 | 101 | $85,951 | $22,328 | 26.0% |
About Dr. James Evanson, MD
Dr. James Evanson, MD is a Internal Medicine healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093715435.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Evanson, MD has received a total of $17,125 in payments from pharmaceutical and medical device companies, with $10,491 received in 2024. These payments were reported across 250 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,258).
As a Medicare-enrolled provider, Evanson has provided services to 2,809 Medicare beneficiaries, totaling 6,481 services with total Medicare billing of $665,942. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Evansville, IN
- Active Since 07/28/2005
- Last Updated 04/03/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093715435
Products in Payments
- Kerendia (Drug) $12,780
- ACTHAR (Biological) $699.82
- JYNARQUE (Drug) $452.35
- FARXIGA (Drug) $434.08
- Auryxia (Drug) $311.27
- Veltassa (Drug) $310.41
- LOKELMA (Drug) $248.40
- TARPEYO (Drug) $196.57
- PURIFIED CORTROPHIN GEL (Drug) $164.59
- INVOKANA (Drug) $124.46
- Rayaldee (Drug) $122.77
- Crysvita (Drug) $110.46
- Parsabiv (Biological) $100.14
- Velphoro (Drug) $86.36
- SAMSCA (Drug) $78.72
- AURYXIA (Drug) $67.82
- BENLYSTA (Biological) $62.75
- TAVNEOS (Drug) $58.87
- ENTRESTO (Drug) $56.61
- JARDIANCE (Drug) $50.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Evansville
Dr. Douglas Sheffer, Md, MD
Internal Medicine — Payments: $77,392
Internal Medicine $77,392
Dr. Narothama Reddy Aeddula, Md, MD
Internal Medicine — Payments: $75,760
Internal Medicine $75,760
Dr. Karl Sash, Md, MD
Internal Medicine — Payments: $63,464
Internal Medicine $63,464
Adeel Siddiqui, M.d, M.D
Internal Medicine — Payments: $21,524
Internal Medicine $21,524
Anthony Voelkel, Md, MD
Internal Medicine — Payments: $19,840
Internal Medicine $19,840
Cameron Whitler, D.o, D.O
Internal Medicine — Payments: $15,807
Internal Medicine $15,807